Drugs / Sertindole
Trials 14 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 37 trials | ||||||
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
| Phase 3 | NCT01765829 | Nov 2012 → Nov 2015 | psychotic disorder | Fundación Pública Andaluza Progreso y Salud | Unknown | No outcome recorded |
| Phase 3 | NCT00654706 | Mar 2008 → Jan 2010 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 3 | NCT00864045 | Mar 2007 → Mar 2008 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 3 | NCT00759460 | Mar 2007 → Mar 2008 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 3 | NCT00759421 | Oct 2006 → Mar 2008 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 3 | NCT00856583 | Jul 2002 → Feb 2008 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 44 trials | ||||||
| Phase 4 | NCT02307396 | Feb 2015 → Jun 2016 | schizoaffective disorder, schizophrenia | Technical University of Munich | Completed | No outcome recorded |
| Phase 4 | NCT00480844 | Oct 2008 → Oct 2011 | schizophrenia | Sheba Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT02021201 | Jul 2008 → Jul 2013 | schizophrenia | Birte Glenthoj | Terminated | No outcome recorded |
| Phase 4 | NCT00763438 | Nov 2007 → Jul 2010 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT00629252 | Feb 2008 → Aug 2012 | schizophrenia | University of Zurich | Terminated | No outcome recorded |
| — | NCT00612079 | Sep 2007 → Oct 2008 | — | University of Zurich | Completed | No outcome recorded |
| — | NCT00345982 | Sep 2006 → Sep 2010 | schizophrenia | University of Aarhus | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00885690 Comparator | Apr 2009 → Nov 2012 | schizophrenia | University of Aarhus | Terminated | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sertindole | “Drugs: Aripiprazole, Olanzapine, Zuclopenthixol, Clotiapine, Flupentixol, Risperidone, Sulpiride, Trifluoperazine, Haloperidol, Quetiapine, Paliperidone, Chlorpromazine,...” NCT01765829 ↗ |
| Known as | LU 23-174 | ChEMBL registry synonym — accepted as the source's own label CHEMBL12713 ↗ |
| Known as | Serdolect | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00345982 ↗ |
| Known as | Serlect | ChEMBL registry synonym — accepted as the source's own label CHEMBL12713 ↗ |
| Known as | Sertindol | ChEMBL registry synonym — accepted as the source's own label CHEMBL12713 ↗ |
| Known as | Zerdol | ChEMBL registry synonym — accepted as the source's own label CHEMBL12713 ↗ |
| Action | Inhibit | “atypical antipsychotic and mixed 5-HT2/D2 antagonist sertindole” NCT00629252 ↗1“Dopamine D2 receptor antagonist” CHEMBL12713 ↗ |
| Modality | Small molecule | — CHEMBL12713 ↗ |
| Route | Oral | “Oral (tablets)” NCT00480844 ↗ |
| Target | DRD2 | “Dopamine D2 receptor antagonist” CHEMBL12713 ↗ |